Coya Therapeutics (COYA) Non-Current Deffered Revenue (2023 - 2026)
Coya Therapeutics' Non-Current Deffered Revenue was $519,636 in Q2 2026, down 19.0% from $641,158 a year earlier and down 31.1% from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Non-Current Deffered Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Deffered Revenue at Coya Therapeutics came in at $1.05 million, up 11.1% from FY2024.
- In earlier years, Non-Current Deffered Revenue was $945,447 in FY2024 (+64.5%) and $574,685 in FY2023.
- The Q2 2026 figure marks the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2023.
- Compared with a year earlier, Non-Current Deffered Revenue was higher in four of the last seven quarters, with growth averaging 4.5%.
- Per Business Quant data, COYA's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $754,198 (Q1 2026), $1.05 million (Q4 2025) and $1.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Coya Therapeutics | 98.99 Mn | -69.89 Mn | - | 519,636.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 519,636.00 |
| Mar 31, 2026 | 754,198.00 |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 641,158.00 |
| Mar 31, 2025 | 694,435.00 |
| Dec 31, 2024 | 945,447.00 |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 856,650.00 |
| Mar 31, 2024 | 681,287.00 |
| Dec 31, 2023 | 574,685.00 |
API Access
Coya Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();